Nkarta, Inc. announced that George Vratsanos, M.D., FACR, is joining its board of directors. Dr. Vratsanos currently serves as chief medical officer and Head of R&D for Jnana Therapeutics where he oversees the company?s R&D work to treat phenylketonuria and a broad range of immune-mediated diseases. He previously held R&D leadership roles as Senior Vice President of Translational Science and Medicine, Immunology at Janssen Pharmaceuticals, Executive Global Program Head of the Immunology and Dermatology Franchise at Novartis, as well as a Translational Medicine Leader at Roche and a Group Director at Bristol Meyers Squibb.

Dr. Vratsanos graduated from New York University (NYU) School of Medicine with honors and completeda postdoctoral fellowship in investigative rheumatology/immunobiology at Yale University. He also earned a master?s degree in clinical investigation from Vanderbilt University, as well as a bachelor?s degree and master?s degree in biomedical engineering from Columbia University.